References |
Top |
REF 1 |
TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell. 1996 Jan 26;84(2):299-308.
|
REF 2 |
De-ubiquitinating protease USP2a targets RIP1 and TRAF2 to mediate cell death by TNF. Cell Death Differ. 2012 May;19(5):891-9.
|
REF 3 |
USP8 suppresses death receptor-mediated apoptosis by enhancing FLIPL stability. Oncogene. 2017 Jan 26;36(4):458-470.
|
REF 4 |
TNF-alpha induces matrix metalloproteinase-9 expression in A549 cells: role of TNFR1/TRAF2/PKCalpha-dependent signaling pathways. J Cell Physiol. 2010 Aug;224(2):454-64.
|
REF 5 |
Brazilin selectively disrupts proximal IL-1 receptor signaling complex formation by targeting an IKK-upstream signaling components. Biochem Pharmacol. 2014 Jun 15;89(4):515-25.
|
REF 6 |
TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity. 1996 Apr;4(4):387-96.
|
REF 7 |
IL-6 cytoprotection in hyperoxic acute lung injury occurs via suppressor of cytokine signaling-1-induced apoptosis signal-regulating kinase-1 degradation. Am J Respir Cell Mol Biol. 2009 Mar;40(3):314-24.
|
REF 8 |
Nonstructural 5A protein of hepatitis C virus modulates tumor necrosis factor alpha-stimulated nuclear factor kappa B activation. J Biol Chem. 2002 Apr 12;277(15):13122-8.
|
REF 9 |
TRAF2 must bind to cellular inhibitors of apoptosis for tumor necrosis factor (tnf) to efficiently activate nf-{kappa}b and to prevent tnf-induced apoptosis. J Biol Chem. 2009 Dec 18;284(51):35906-15.
|
REF 10 |
Novel anti-apoptotic mechanism of A20 through targeting ASK1 to suppress TNF-induced JNK activation. Cell Death Differ. 2010 Dec;17(12):1830-41.
|
REF 11 |
Competitive control of independent programs of tumor necrosis factor receptor-induced cell death by TRADD and RIP1. Mol Cell Biol. 2006 May;26(9):3505-13.
|
REF 12 |
IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis. Cell. 2007 Nov 16;131(4):682-93.
|
REF 13 |
Celastrol-Induced Nur77 Interaction with TRAF2 Alleviates Inflammation by Promoting Mitochondrial Ubiquitination and Autophagy. Mol Cell. 2017 Apr 6;66(1):141-153.e6.
|
REF 14 |
The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complex. Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):13973-8.
|
REF 15 |
Sequestration of TRAF2 into stress granules interrupts tumor necrosis factor signaling under stress conditions. Mol Cell Biol. 2005 Mar;25(6):2450-62.
|
REF 16 |
Syk-mediated tyrosine phosphorylation of mule promotes TNF-induced JNK activation and cell death. Oncogene. 2016 Apr 14;35(15):1988-95.
|
REF 17 |
Using an in situ proximity ligation assay to systematically profile endogenous protein-protein interactions in a pathway network. J Proteome Res. 2014 Dec 5;13(12):5339-46.
|
REF 18 |
The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell. 1995 Feb 10;80(3):389-99.
|
REF 19 |
Architecture of the human interactome defines protein communities and disease networks. Nature. 2017 May 25;545(7655):505-509.
|
REF 20 |
RAIDD is a new 'death' adaptor molecule. Nature. 1997 Jan 2;385(6611):86-9.
|
REF 21 |
c-IAP1 and UbcH5 promote K11-linked polyubiquitination of RIP1 in TNF signalling. EMBO J. 2010 Dec 15;29(24):4198-209.
|
REF 22 |
Ubiquitin-associated domain-containing ubiquitin regulatory X (UBX) protein UBXN1 is a negative regulator of nuclear factor B (NF-B) signaling. J Biol Chem. 2015 Apr 17;290(16):10395-405.
|
REF 23 |
The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs. Mol Cell. 2011 Aug 5;43(3):432-48.
|
REF 24 |
CYLD deubiquitinates RIP1 in the TNF-induced necrosome to facilitate kinase activation and programmed necrosis. PLoS One. 2013 Oct 2;8(10):e76841.
|
REF 25 |
Linear ubiquitination is involved in the pathogenesis of optineurin-associated amyotrophic lateral sclerosis. Nat Commun. 2016 Aug 24;7:12547.
|
REF 26 |
Modulation of RIP1 ubiquitylation and distribution by MeBS to sensitize cancer cells to tumor necrosis factor -induced apoptosis. Cancer Sci. 2010 Nov;101(11):2425-9.
|
REF 27 |
Down-regulation of c-FLIP Enhances death of cancer cells by smac mimetic compound. Cancer Res. 2009 Oct 1;69(19):7729-38.
|
REF 28 |
S-Nitrosylation of cIAP1 Switches Cancer Cell Fate from TNF/TNFR1-Mediated Cell Survival to Cell Death. Cancer Res. 2018 Apr 15;78(8):1948-1957.
|
REF 29 |
Tautomycetin suppresses the TNFalpha/NF-kappaB pathway via inhibition of IKK activation. Int J Oncol. 2008 Nov;33(5):1027-35.
|
REF 30 |
Recruitment of A20 by the C-terminal domain of NEMO suppresses NF-B activation and autoinflammatory disease. Proc Natl Acad Sci U S A. 2016 Feb 9;113(6):1612-7.
|
REF 31 |
USP4 targets TAK1 to downregulate TNF-induced NF-B activation. Cell Death Differ. 2011 Oct;18(10):1547-60.
|
REF 32 |
Triad3A regulates ubiquitination and proteasomal degradation of RIP1 following disruption of Hsp90 binding. J Biol Chem. 2006 Nov 10;281(45):34592-600.
|
REF 33 |
De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature. 2004 Aug 5;430(7000):694-9.
|
REF 34 |
Ubiquitin binding modulates IAP antagonist-stimulated proteasomal degradation of c-IAP1 and c-IAP2(1). Biochem J. 2009 Jan 1;417(1):149-60.
|
REF 35 |
Ubiquitin chain editing revealed by polyubiquitin linkage-specific antibodies. Cell. 2008 Aug 22;134(4):668-78.
|
REF 36 |
Phospho-SXXE/D motif mediated TNF receptor 1-TRADD death domain complex formation for T cell activation and migration. J Immunol. 2011 Aug 1;187(3):1289-97.
|
REF 37 |
Activation of the NF-kappaB pathway by caspase 8 and its homologs. Oncogene. 2000 Sep 14;19(39):4451-60.
|
REF 38 |
Induction of Jak/STAT signaling by activation of the type 1 TNF receptor. J Immunol. 1998 Mar 15;160(6):2742-50.
|
REF 39 |
Type 1 TNF receptor forms a complex with and uses Jak2 and c-Src to selectively engage signaling pathways that regulate transcription factor activity. J Immunol. 2008 Jul 15;181(2):1288-98.
|
REF 40 |
The mammalian-membrane two-hybrid assay (MaMTH) for probing membrane-protein interactions in human cells. Nat Methods. 2014 May;11(5):585-92.
|
REF 41 |
In silico prediction of physical protein interactions and characterization of interactome orphans. Nat Methods. 2015 Jan;12(1):79-84.
|
REF 42 |
Tumor necrosis factor alpha (TNF-alpha) activates Jak1/Stat3-Stat5B signaling through TNFR-1 in human B cells. Cell Growth Differ. 2002 Jan;13(1):13-8.
|
REF 43 |
Inflammatory protein sPLA(2)-IIA abrogates TNFalpha-induced apoptosis in human astroglioma cells: Crucial role of ERK. Biochim Biophys Acta. 2009 Dec;1793(12):1837-47.
|
REF 44 |
Heterogeneity in the phosphorylation of human death receptors by p42(mapk/erk2). Biochem Biophys Res Commun. 2001 Oct 26;288(2):313-20.
|
REF 45 |
A protein related to a proteasomal subunit binds to the intracellular domain of the p55 TNF receptor upstream to its 'death domain'. FEBS Lett. 1995 Jun 19;367(1):39-44.
|
REF 46 |
Two-hybrid cloning of a gene encoding TNF receptor-associated protein 2, a protein that interacts with the intracellular domain of the type 1 TNF receptor: identity with subunit 2 of the 26S protease. J Immunol. 1997 May 1;158(9):4252-9.
|
REF 47 |
Prevention of constitutive TNF receptor 1 signaling by silencer of death domains. Science. 1999 Jan 22;283(5401):543-6.
|
REF 48 |
AIP1/DAB2IP, a novel member of the Ras-GAP family, transduces TRAF2-induced ASK1-JNK activation. J Biol Chem. 2004 Oct 22;279(43):44955-65.
|
REF 49 |
The ectodermal dysplasia receptor activates the nuclear factor-kappaB, JNK, and cell death pathways and binds to ectodysplasin A. J Biol Chem. 2001 Jan 26;276(4):2668-77.
|
REF 50 |
SH3RF2 functions as an oncogene by mediating PAK4 protein stability. Carcinogenesis. 2014 Mar;35(3):624-34.
|
REF 51 |
A novel TLR2-triggered signalling crosstalk synergistically intensifies TNF-mediated IL-6 induction. J Cell Mol Med. 2014 Jul;18(7):1344-57.
|
REF 52 |
Inhibition of receptor internalization by monodansylcadaverine selectively blocks p55 tumor necrosis factor receptor death domain signaling. J Biol Chem. 1999 Apr 9;274(15):10203-12.
|
REF 53 |
The receptor for the cytotoxic ligand TRAIL. Science. 1997 Apr 4;276(5309):111-3.
|
REF 54 |
CLIPR-59 regulates TNF--induced apoptosis by controlling ubiquitination of RIP1. Cell Death Dis. 2012 Feb 2;3:e264.
|
REF 55 |
The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell. 1995 May 19;81(4):495-504.
|
REF 56 |
A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway. Nat Cell Biol. 2004 Feb;6(2):97-105.
|
REF 57 |
Recruitment of TNF receptor 1 to lipid rafts is essential for TNFalpha-mediated NF-kappaB activation. Immunity. 2003 May;18(5):655-64.
|
REF 58 |
Identification of a 60-kD tumor necrosis factor (TNF) receptor as the major signal transducing component in TNF responses. J Exp Med. 1990 Oct 1;172(4):1019-23.
|
REF 59 |
Production of lymphotoxin (LT alpha) and a soluble dimeric form of its receptor using the baculovirus expression system. J Immunol Methods. 1994 Jan 12;168(1):79-89.
|
REF 60 |
Insertion of foreign T cell epitopes in human tumor necrosis factor alpha with minimal effect on protein structure and biological activity. J Biol Chem. 2004 Aug 6;279(32):33593-600.
|
REF 61 |
Identification of tumor necrosis factor (TNF) amino acids crucial for binding to the murine p75 TNF receptor and construction of receptor-selective mutants. J Biol Chem. 2001 Oct 5;276(40):37426-30.
|
REF 62 |
Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation. Cell. 1993 May 7;73(3):431-45.
|
REF 63 |
Cytoskeleton-mediated death receptor and ligand concentration in lipid rafts forms apoptosis-promoting clusters in cancer chemotherapy. J Biol Chem. 2005 Mar 25;280(12):11641-7.
|